Verified peer comparison
GP-Act III Acquisition vs Valion Bio Financial Comparison
Direct answer
GP-Act III Acquisition and Valion Bio are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free GP-Act III Acquisition email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- GP-Act III Acquisition Revenue
- 0 USD
- Valion Bio Revenue
- 382,000 USD
- GP-Act III Acquisition Operating income
- -551,918 USD
- Valion Bio Operating income
- -768,000 USD